Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ACLX - Arcellx, Inc.
Market Cap 1.64B P/E - EPS this Y -6.80% Ern Qtrly Grth -
Income -50.54M Forward P/E -11.03 EPS next Y -35.00% 50D Avg Chg -6.00%
Sales 131.66M PEG -0.58 EPS past 5Y - 200D Avg Chg 9.00%
Dividend N/A Price/Book 5.39 EPS next 5Y 69.30% 52W High Chg -30.00%
Recommedations 1.60 Quick Ratio 5.35 Shares Outstanding 53.50M 52W Low Chg 119.00%
Insider Own 12.81% ROA -6.71% Shares Float 34.70M Beta 0.22
Inst Own 89.57% ROE -12.63% Shares Shorted/Prior 5M/4.81M Price 34.20
Gross Margin 100.00% Profit Margin -38.39% Avg. Volume 563,691 Target Price 79.93
Oper. Margin -40.27% Earnings Date - Volume 436,561 Change 0.06%
Healthcare | Biotechnology | United States
About Arcellx, Inc.

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In addition, the company's preclinical product includes ACLX-003 for the treatment of AML and MDS. Further, it focuses on the development of product candidates for solid tumor programs. It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize anitocabtagene autoleucel. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Arcellx, Inc. News
07/04/24 FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
06/29/24 Insider Sale: CFO Michelle Gilson Sells 12,877 Shares of Arcellx Inc (ACLX)
06/22/24 We Think Arcellx (NASDAQ:ACLX) Can Easily Afford To Drive Business Growth
06/21/24 Arcellx Stock Earns Relative Strength Rating Upgrade
05/27/24 7 Biotech Stocks to Put on Your Breakthrough Radar
05/25/24 Insider Sale: CFO Michelle Gilson Sells Shares of Arcellx Inc (ACLX)
05/17/24 Private Equity Prowl: 3 Overlooked Stocks Primed for Buyout Bids
05/12/24 Arcellx First Quarter 2024 Earnings: Beats Expectations
05/10/24 Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge
05/10/24 Kite and Arcellx prepare to launch Phase III multiple myeloma trial
05/09/24 Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates
05/09/24 Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
05/09/24 Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
05/09/24 Arcellx Provides First Quarter 2024 Financial Results
05/09/24 Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
05/07/24 Arcellx to Participate in Two Upcoming Investor Conferences
04/23/24 Should You Be Bullish on Arcellx (ACLX)?
04/04/24 Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
04/04/24 How Arcellx (ACLX) Stock Stands Out in a Strong Industry
03/28/24 Insiders Are Dumping These 10 Healthcare Stocks
ACLX Chatroom

User Image Thestocktraderhubzee Posted - 4 days ago

$ACLX Canaccord Genuity Maintains Buy on Arcellx, Maintains $85 Price Target

User Image insiderbuyingselling Posted - 1 week ago

$ACLX new insider selling: 10901 shares. http://insiderbuyingselling.com/?t=ACLX

User Image Doozio Posted - 1 week ago

$ACLX $XBI bahhhht who gives a FOOK? It’s 🧠⏰ in 2020FOUR!!

User Image FlynancialAnalyst Posted - 1 week ago

$ACLX $3.17B mc $XBI #HiddenGem (only 225 watchers on Stocktwits) rotating up to 3 mo. highs off rising 40 wk SMA on volume Short float % is in a 9 mo.+ downtrend relative to the Sep. '23 highs of 26.66% #Squeeze Pct. of all funds long shares at record highs & trending higher TrendEdge.app/asset/ACLX

User Image norsetrader1 Posted - 1 week ago

$ACLX pending catalyst? options on this is wild

User Image insiderbuyingselling Posted - 2 weeks ago

$ACLX new insider selling: 5451 shares. http://insiderbuyingselling.com/?t=ACLX

User Image insiderbuyingselling Posted - 2 weeks ago

$ACLX new insider selling: 1500 shares. http://insiderbuyingselling.com/?t=ACLX

User Image TickerDD_com Posted - 3 weeks ago

From 6/14/2024, looking back across 21 Month-Ends for ACLX, Percentage Change of Average Monthly Price had More Positives (77%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ACLX #ACLX #ACLXStock #TickerDD #ACLXPrice https://www.youtube.com/watch?v=ybHHGuKeRKs

User Image Doozio Posted - 3 weeks ago

$ACLX new Druck pos n da 🧠 is medicated with fresh huckleberries in 🧠⏰

User Image GPS_hawkeye Posted - 06/29/24

$SAVA $XBI https://finance.yahoo.com/news/stock-market-crash-warning-don-171620656.html note some insider sales at mid-larger biotechs $ACLX $650-700k $VRTX $1.3 million

User Image InsiderPeek Posted - 06/28/24

$ACLX CFO Gilson Michelle sold 12.9k shares for $691.5k (ownership down 65.06%) insiderpeek.com/company/ACLX

User Image Traderdogzz21 Posted - 1 month ago

$ACLX

User Image DonCorleone77 Posted - 05/31/24

$ACLX Arcellx initiated with an Overweight at Piper Sandler Piper Sandler analyst Biren Amin initiated coverage of Arcellx with an Overweight rating and $70 price target. The analyst cites the company's "potentially differentiated" profile of anito-cel as a treatment in multiple myeloma for the buy rating, saying Arcellx expects to provide an interim update from the iMMagine-1 trial at year-end.

User Image Thestocktraderhubzee Posted - 2 months ago

WATCHLIST MAY 14 2024.. $SWIM Barclays Maintains Equal-Weight on Latham Group, Raises Price Target to $4 $TIXT Barclays Maintains Equal-Weight on TELUS Intl, Lowers Price Target to $7 $NKTX HC Wainwright & Co. Maintains Buy on Nkarta, Raises Price Target to $23 $CRBU HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $24 Price Target $ACLX HC Wainwright & Co. Maintains Buy on Arcellx, Lowers Price Target to $80

User Image Stocksrunner Posted - 2 months ago

📊Key Technical Indicators Update: $ACLX, $DCBO, $AMR, and $PBF slipped below their 200-day moving averages, indicating possible bearish trends. 📉💔

User Image Stock_Titan Posted - 2 months ago

$GILD $ACLX Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program https://www.stocktitan.net/news/GILD/kite-and-arcellx-continue-momentum-with-advances-in-anito-cel-ga2mar63tq6o.html

User Image Stock_Titan Posted - 2 months ago

$ACLX $GILD Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program https://www.stocktitan.net/news/ACLX/arcellx-and-kite-continue-momentum-with-advances-in-anito-cel-iwhqjy25gvt1.html

User Image Stock_Titan Posted - 2 months ago

$ACLX Arcellx Provides First Quarter 2024 Financial Results https://www.stocktitan.net/news/ACLX/arcellx-provides-first-quarter-2024-financial-t5tuhtqagy0n.html

User Image insiderbuyingselling Posted - 2 months ago

$ACLX new insider selling: 18168 shares. http://insiderbuyingselling.com/?t=ACLX

User Image insiderbuyingselling Posted - 3 months ago

$ACLX new insider selling: 9402 shares. http://insiderbuyingselling.com/?t=ACLX

User Image Quantumup Posted - 3 months ago

BMO Capital $LEGN Outperform/$90: "1Q24 Sales Missed Consensus by ~8%; We Don't see any Long-Term Impact" BMO expects the 2L approval2 sig'ly expand the addressable pop/demand +w/ mfg'g scaling will enable Carvykti sales2meet/beat '24 cons expys (~$1B): $ACLX $jnj $gild $tsvt bmy

User Image svb64 Posted - 3 months ago

$ACLX where is this going to land?

User Image Stock_Titan Posted - 3 months ago

$ACLX Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/ACLX/arcellx-to-participate-in-the-23rd-annual-needham-virtual-healthcare-xb5jsp4n57mu.html

User Image InsiderPeek Posted - 3 months ago

$ACLX CEO Elghandour Rami sold 23.1k shares for $1.5 millions (ownership down 25.0%) insiderpeek.com/company/ACLX

User Image insiderbuyingselling Posted - 4 months ago

$ACLX new insider selling: 46815 shares. http://insiderbuyingselling.com/?t=ACLX

User Image insiderbuyingselling Posted - 4 months ago

$ACLX new insider selling: 504263 shares. http://insiderbuyingselling.com/?t=ACLX

User Image Stock_Titan Posted - 4 months ago

$ACLX Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference https://www.stocktitan.net/news/ACLX/arcellx-to-participate-at-the-h-c-wainwright-2nd-annual-cell-therapy-510f6hq5ceyj.html

User Image insiderbuyingselling Posted - 4 months ago

$ACLX new insider selling: 6825 shares. http://insiderbuyingselling.com/?t=ACLX

User Image Thestocktraderhubzee Posted - 4 months ago

$ACLX Needham Maintains Buy on Arcellx, Raises Price Target to $81

User Image Doorkey Posted - 4 months ago

$ACLX $$$$

Analyst Ratings
Canaccord Genuity Buy Jul 22, 24
Truist Securities Buy Jun 18, 24
Piper Sandler Overweight May 31, 24
Stifel Buy May 15, 24
Evercore ISI Group Outperform May 14, 24
HC Wainwright & Co. Buy May 13, 24
Needham Buy May 10, 24
Needham Buy May 7, 24
Needham Buy Apr 11, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Heery Christopher Chief Medical Office.. Chief Medical Officer Jan 02 Option 0.00 16,519 25,457 01/04/24
Gilson Michelle Chief Financial Offi.. Chief Financial Officer Jan 02 Option 0.00 15,339 24,824 01/04/24
Elghandour Rami See Remarks See Remarks Jan 02 Option 0.00 53,097 89,266 01/04/24
Heery Christopher Chief Medical Office.. Chief Medical Officer Aug 04 Sell 35.38 3,000 106,140 7,795 08/07/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Aug 04 Option 15 3,000 45,000 10,795 08/07/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Jul 03 Sell 31.75 3,000 95,250 7,795 07/05/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Jul 03 Option 15 3,000 45,000 10,795 07/05/23
Elghandour Rami See Remarks See Remarks May 31 Sell 44.2688 2,600 115,099 36,169 06/02/23
Gilson Michelle Chief Financial Offi.. Chief Financial Officer May 23 Sell 42.29 14,704 621,832 9,485 05/25/23
Gilson Michelle Chief Financial Offi.. Chief Financial Officer May 23 Option 0 22,428 24,189 05/25/23
Carroll Jill Director Director May 11 Sell 45.58 638,417 29,099,047 2,828,394 05/15/23
SR ONE CAPITAL MANAGEMENT, LLC 10% Owner 10% Owner May 11 Sell 45.58 1,012,833 46,164,928 1,658,780 05/15/23
Heery Christopher Chief Medical Office.. Chief Medical Officer May 05 Sell 45.0017 1,200 54,002 10,492 05/08/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Apr 03 Sell 30.9 3,000 92,700 15,589 04/04/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Apr 03 Option 15 3,000 45,000 18,589 04/04/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Feb 07 Sell 30.77 6,966 214,344 15,589 02/09/23
Heery Christopher Chief Medical Office.. Chief Medical Officer Feb 07 Option 0 22,555 22,555 02/09/23
Elghandour Rami See Remarks See Remarks Feb 07 Sell 30.77 31,442 967,470 38,769 02/09/23
Elghandour Rami See Remarks See Remarks Feb 07 Option 0 70,211 70,211 02/09/23
SANDELL SCOTT D 10% Owner 10% Owner Dec 23 Sell 31.67 390 12,351 12/27/22
SANDELL SCOTT D 10% Owner 10% Owner Dec 20 Sell 30.74 179 5,502 12/22/22
New Enterprise Associates 15,... 10% Owner 10% Owner Jun 21 Buy 16.00 312,500 5,000,000 6,745,262 06/23/22
SR ONE CAPITAL MANAGEMENT, LLC 10% Owner 10% Owner Feb 08 Buy 15 1,666,667 25,000,005 2,033,196 02/10/22
New Enterprise Associates 15,... 10% Owner 10% Owner Feb 08 Buy 15 1,583,333 23,749,995 6,432,762 02/09/22
Carroll Jill Director Director Feb 08 Buy 15 1,666,667 25,000,005 2,033,196 02/09/22
Novo Holdings A/S 10% Owner 10% Owner Feb 08 Buy 15 833,333 12,499,995 4,016,878 02/09/22